NO162720C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-dihydro-6-/2-/4(1h-imidazol-1-yl)fenyl/etenyl/-3(2h)pyridazinonforbindelser. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-dihydro-6-/2-/4(1h-imidazol-1-yl)fenyl/etenyl/-3(2h)pyridazinonforbindelser.

Info

Publication number
NO162720C
NO162720C NO844883A NO844883A NO162720C NO 162720 C NO162720 C NO 162720C NO 844883 A NO844883 A NO 844883A NO 844883 A NO844883 A NO 844883A NO 162720 C NO162720 C NO 162720C
Authority
NO
Norway
Prior art keywords
pyridazinon
ethenyl
imidazol
dihydro
phenyl
Prior art date
Application number
NO844883A
Other languages
English (en)
Norwegian (no)
Other versions
NO162720B (no
NO844883L (no
Inventor
Ila Sircar
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO844883L publication Critical patent/NO844883L/no
Publication of NO162720B publication Critical patent/NO162720B/no
Publication of NO162720C publication Critical patent/NO162720C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO844883A 1983-12-07 1984-12-06 Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-dihydro-6-/2-/4(1h-imidazol-1-yl)fenyl/etenyl/-3(2h)pyridazinonforbindelser. NO162720C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55916183A 1983-12-07 1983-12-07
US06/669,323 US4599332A (en) 1983-12-07 1984-11-09 4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]-ethenyl]-3(2H)-pyridazinones and related compounds

Publications (3)

Publication Number Publication Date
NO844883L NO844883L (no) 1985-06-10
NO162720B NO162720B (no) 1989-10-30
NO162720C true NO162720C (no) 1990-02-07

Family

ID=27071977

Family Applications (1)

Application Number Title Priority Date Filing Date
NO844883A NO162720C (no) 1983-12-07 1984-12-06 Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-dihydro-6-/2-/4(1h-imidazol-1-yl)fenyl/etenyl/-3(2h)pyridazinonforbindelser.

Country Status (16)

Country Link
US (1) US4599332A (fi)
EP (1) EP0145450B1 (fi)
KR (1) KR880002531B1 (fi)
AU (1) AU562172B2 (fi)
CA (1) CA1244828A (fi)
DE (1) DE3479729D1 (fi)
DK (1) DK578484A (fi)
ES (1) ES538242A0 (fi)
FI (1) FI75819C (fi)
GR (1) GR81189B (fi)
HU (1) HU193065B (fi)
IL (1) IL73628A (fi)
NO (1) NO162720C (fi)
NZ (1) NZ210458A (fi)
PH (1) PH20975A (fi)
PT (1) PT79627B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61158969A (ja) * 1984-12-24 1986-07-18 ワーナー‐ランバート・コンパニー 4,5‐ジヒドロ‐4,4‐ジアルキル‐6‐(置換)フエニル‐3(2h)‐ピリダジノン類
DE3505609A1 (de) * 1985-02-19 1986-08-21 Merck Patent Gmbh, 6100 Darmstadt Benzimidazolyl-pyridazinone
IL79280A (en) * 1985-07-05 1990-07-12 Smith Kline French Lab 4-(6-oxo-dihydro or tetrahydropyridazin-3-yl)benzene derivatives,their preparation and pharmaceutical compositions containing them
US4826835A (en) * 1985-10-23 1989-05-02 Rorer Pharmaceutical Corporation Pyridyl-pyridazinone and pyridyl-pyrazolinone compounds and their use in the treatment of congestive heart failure
US4783463A (en) * 1985-10-23 1988-11-08 Rorer Pharmaceutical Corporation Pyridyl-pyridazinone and pyridyl-pyrazolinone compounds and their use in the treatment of congestive heart failure
GB8903130D0 (en) * 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
US5185332A (en) * 1989-02-11 1993-02-09 Orion-Yhtyma Oy Thiadiazines and pharmaceutical compositions thereof as well as method of use
CA2205757C (en) * 1996-05-30 2006-01-24 F. Hoffmann-La Roche Ag Pyridazinone derivatives and their use as inhibitors of prostaglandin g/h synthase i and ii(cox i and ii)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3130251A1 (de) * 1981-07-31 1983-02-17 A. Nattermann & Cie GmbH, 5000 Köln 6-(4-((omega)-(1-imidazolyl)-alkyl)-phenyl)-3-oxo -2,3,4,5-tetrahydro-pyridazine und deren saeureadditionssalze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3130252A1 (de) * 1981-07-31 1983-02-17 A. Nattermann & Cie GmbH, 5000 Köln 6-(5-((omega)-(1-imidazolyl)-alkyl)-thien-2-yl)-3-oxo-2,3,4,5-tetrahydro-pyridazine und deren saeureadditionssalze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
HU190412B (en) * 1981-09-17 1986-09-29 Warner-Lambert Co,Us Process for producing substituted 4,5-dihiydro-6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones and 6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones
US4353905A (en) * 1981-09-17 1982-10-12 Warner-Lambert Company Substituted 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and 6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones
CA1199027A (en) * 1981-11-12 1986-01-07 Stuart D. Mills Heterocyclic derivatives of pyridazinone, thiadiazinone, oxadiazinone and triazinone
DE3212304A1 (de) * 1982-04-02 1983-10-06 Nattermann A & Cie Imidazolylphenyl-tetrahydropyridazine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4508718A (en) * 1984-01-16 1985-04-02 Warner-Lambert Company Cardiotonic and antihypertensive oxadiazinone compounds
DE3401911A1 (de) * 1984-01-20 1985-08-01 A. Nattermann & Cie GmbH, 5000 Köln Substituierte 4,5-dihydro-6-vinyl-3(2h)-pyridazinone und 6-vinyl-3(2h)-pyridazinone sowie verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
EP0145450B1 (en) 1989-09-13
FI844822L (fi) 1985-06-08
KR850004481A (ko) 1985-07-15
ES8602772A1 (es) 1985-12-01
NO162720B (no) 1989-10-30
EP0145450A2 (en) 1985-06-19
FI844822A0 (fi) 1984-12-05
US4599332A (en) 1986-07-08
HU193065B (en) 1987-08-28
IL73628A0 (en) 1985-02-28
AU3635584A (en) 1985-06-13
IL73628A (en) 1987-10-20
FI75819C (fi) 1988-08-08
DK578484D0 (da) 1984-12-05
GR81189B (en) 1985-04-08
DE3479729D1 (en) 1989-10-19
ES538242A0 (es) 1985-12-01
EP0145450A3 (en) 1986-11-26
CA1244828A (en) 1988-11-15
DK578484A (da) 1985-06-08
PH20975A (en) 1987-06-15
NO844883L (no) 1985-06-10
NZ210458A (en) 1987-06-30
HUT36473A (en) 1985-09-30
KR880002531B1 (ko) 1988-11-28
PT79627A (en) 1985-01-01
AU562172B2 (en) 1987-05-28
FI75819B (fi) 1988-04-29
PT79627B (en) 1986-12-12

Similar Documents

Publication Publication Date Title
NO156752B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(1-piperidinylalkyl)-4hpyrido(1,2-a)pyrimidin-4-0n derivater
NO166232C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(5-aminopentyl)-amino-1-benzazepin-2-on-1-alkansyrer.
NO159016C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminderivater.
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO165239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater.
NO165192C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO165027C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive propenyl-cefalosporinforbindelser.
NO821085L (no) Fremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater
NO164168C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,7,4-triazolforbindelser.
NO814424L (no) Fremgangsmaate for fremstilling av terapeutisk virksomme 5,5`-azobis-salisylsyreforbindelser.
NO156694C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-(1,2-propadienyl)-steroider.
NO159930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater.
NO161562C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO158460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO159291C (no) Fremgangsmaate for fremstilling av gamma-substituerte 3(r)-hydroxysmoersyrederivater.
NO158941C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO162720C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-dihydro-6-/2-/4(1h-imidazol-1-yl)fenyl/etenyl/-3(2h)pyridazinonforbindelser.
NO158673C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.
NO163570C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acylaminomitosaner.
NO164095C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av 3-(3-substituerte-amino-2-hydroksypropoksy)-4-substituerte-1,2,5-tiadiazolderivater.
NO157618C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzamid-inderivater.
NO163617C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolidinon-derivater.
NO163327C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydropyridiner.
NO157575C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-dihydropyridin-derivater.
NO157101C (no) AnalogifremgangsmŸte for fremstilling av terapeutisk aktive anilino-1,2,3-triazol-derivater.